BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24528498)

  • 41. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?
    Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B
    Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectious complications in pulmonary allograft recipients.
    Dauber JH; Paradis IL; Dummer JS
    Clin Chest Med; 1990 Jun; 11(2):291-308. PubMed ID: 2189664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Infections in organ transplantations].
    Holzinger C; Buxbaum P; Laczkovics A; Domanig E; Wolner E
    Zentralbl Chir; 1990; 115(17):1091-9. PubMed ID: 2173865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Infectious complications due to immunosuppression in organ transplant patients].
    Morelon E; Touraine JL
    Rev Prat; 2007 Oct; 57(15):1677-86. PubMed ID: 18080426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation.
    Hirsch HH; Babel N; Comoli P; Friman V; Ginevri F; Jardine A; Lautenschlager I; Legendre C; Midtvedt K; Muñoz P; Randhawa P; Rinaldo CH; Wieszek A;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():74-88. PubMed ID: 24476010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infection in renal transplant recipients.
    Fishman JA
    Semin Nephrol; 2007 Jul; 27(4):445-61. PubMed ID: 17616276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Microbiome, Systemic Immune Function, and Allotransplantation.
    Nellore A; Fishman JA
    Clin Microbiol Rev; 2016 Jan; 29(1):191-9. PubMed ID: 26656674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of Infectious Disease Prophylaxis in Solid Organ Transplantation.
    Personett HA; Laub MR
    Crit Care Nurs Q; 2017; 40(4):383-398. PubMed ID: 28834860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiology of invasive fungal infection in solid organ transplant].
    Montejo M
    Rev Iberoam Micol; 2011; 28(3):120-3. PubMed ID: 21700231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infectious disease trends among immunocompromised hosts.
    Young B; Tambyah PA
    Singapore Med J; 2012 Apr; 53(4):223-9; quiz 230. PubMed ID: 22511041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of critical periods for opportunistic infection in the new transplantation era.
    Garrido RS; Aguado JM; Díaz-Pedroche C; Len O; Montejo M; Moreno A; Gurguí M; Torre-Cisneros J; Pareja F; Segovia J; Garcia M; Lumbreras C
    Transplantation; 2006 Dec; 82(11):1457-62. PubMed ID: 17164717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infections in solid organ transplantation in special situations: HIV-infection and immigration.
    Miró JM; Blanes M; Norman F; Martín-Dávila P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():76-85. PubMed ID: 22542039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathogenic analysis of solid organ transplant recipients with pulmonary opportunistic infections via bronchoscopy].
    Chen JN; Jiang P; Zheng H
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):603-5. PubMed ID: 23663342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fungal infections in solid organ transplant patients.
    Hagerty JA; Ortiz J; Reich D; Manzarbeitia C
    Surg Infect (Larchmt); 2003; 4(3):263-71. PubMed ID: 14588161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications.
    Calarota SA; Aberle JH; Puchhammer-Stöckl E; Baldanti F
    J Clin Virol; 2015 Sep; 70():109-119. PubMed ID: 26305832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indirect effects of CMV in the solid organ transplant patient.
    Paya CV
    Transpl Infect Dis; 1999; 1 Suppl 1():8-12. PubMed ID: 11565588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.
    Timsit JF; Sonneville R; Kalil AC; Bassetti M; Ferrer R; Jaber S; Lanternier F; Luyt CE; Machado F; Mikulska M; Papazian L; Pène F; Poulakou G; Viscoli C; Wolff M; Zafrani L; Van Delden C
    Intensive Care Med; 2019 May; 45(5):573-591. PubMed ID: 30911807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin infections in organ transplant recipients.
    Ulrich C; Hackethal M; Meyer T; Geusau A; Nindl I; Ulrich M; Forschner T; Sterry W; Stockfleth E
    J Dtsch Dermatol Ges; 2008 Feb; 6(2):98-105. PubMed ID: 17995969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppression regimens to address alloantibodies in transplant recipients.
    Everly MJ
    Clin Transpl; 2012; ():219-23. PubMed ID: 23721025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.